MegaPro Biomedical 

TWD13.95
0
-TWD0.10-0.71% 06:57 Today

Statistics

Day High
14.25
Day Low
13.9
52W High
16.8
52W Low
9.47
Volume
710,232
Avg. Volume
436,103
Mkt Cap
902.86M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-1,171,721.43%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
28,000Revenue
-328.08MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily focused on pioneering nanodrugs. Its innovative development pipeline includes MPB-1523, an IOP injection currently in Phase II clinical evaluation for addressing hepatocellular carcinoma. Simultaneously, MPB-1514, an iron injection, is also undergoing Phase II clinical trials, targeting iron deficiency anemia. Furthermore, the firm is advancing MPB-1734, an anti-cancer pharmaceutical, which is in preclinical assessment for the treatment of malignant tumors. Established in 2014, this company is headquartered in Zhubei, Taiwan.
Show More
CEO
Jassy Wang
Employees
27
Country
Taiwan
ISIN
TW0006827009

Listings

0 Comments

Share your thoughts

FAQs

What is MegaPro Biomedical stock price today?▼
The current price of 6827.TWO is TWD13.95 TWD — it has decreased by -0.71% in the past 24 hours. Watch MegaPro Biomedical stock price performance more closely on the chart.
What is MegaPro Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange MegaPro Biomedical stocks are traded under the ticker 6827.TWO.
Is MegaPro Biomedical stock price growing?▼
6827.TWO stock has fallen by -0.71% compared to the previous week, the month change is a +5.28% rise, over the last year MegaPro Biomedical has showed a -14.94% decrease.
What is MegaPro Biomedical market cap?▼
Today MegaPro Biomedical has the market capitalization of 902.86M
What is MegaPro Biomedical revenue for the last year?▼
MegaPro Biomedical revenue for the last year amounts to 28,000 TWD.
What is MegaPro Biomedical net income for the last year?▼
6827.TWO net income for the last year is -328.08M TWD.
How many employees does MegaPro Biomedical have?▼
As of November 3, 2026, the company has 27 employees.
In which sector is MegaPro Biomedical located?▼
MegaPro Biomedical operates in the Health & Wellness sector.
When did MegaPro Biomedical complete a stock split?▼
MegaPro Biomedical has not had any recent stock splits.
Where is MegaPro Biomedical headquartered?▼
MegaPro Biomedical is headquartered in Zhubei, Taiwan.